Becton, Dickinson & Co. (BDX)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Apr 17, 2025

$198.71

P/E Ratio

33.01

Market Cap

$57.06B

Description
Add to research
View more

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Metrics
Add to research
View more

Overview

  • HQFranklin Lakes, NJ
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerBDX
  • Price$198.71-0.84%

Trading Information

  • Market cap$57.06B
  • Float99.81%
  • Average Daily Volume (1m)2,501,604
  • Average Daily Volume (3m)2,177,007
  • EPS$6.04

Company

  • Revenue$20.64B
  • Rev growth (1yr)9.82%
  • Net income$303.00M
  • Gross margin43.25%
  • EBITDA margin22.31%
  • EBITDA$1.15B
  • EV$83.81B
  • EV/Revenue4.06
  • P/E33.01
  • P/S2.80
  • P/B2.26
  • Debt/Equity74.42
Documents
Add to research
View more